See 18-20 per cent growth, 10-12 product launches in US: Glenmark

01-Jun-2015 #India-US,#Economy & Trade Source: Money Control
According to CMD Glenn Saldanha, the Indian pharma major Glenmark is expecting an 18-20 per cent growth in the US market in FY16. Glenmark also continues to be a serious player in the diabetes space.
Read Full Article..
Tagged:
Array
(
    [0] => post-template-default
    [1] => single
    [2] => single-post
    [3] => postid-7507
    [4] => single-format-standard
    [5] => do-etfw
    [6] => wpb-js-composer js-comp-ver-3.6.14.1
    [7] => vc_responsive
)
7507false